Table 4.
Group A | Group C | pa,b | |
---|---|---|---|
LiMAx (μg/kg/h) | 71 (37–88) | 438 (330–456) | < 0.001b |
Lactate (mmol/L) | 27 (24–30) | 12 (9–14) | 0.001a |
INR | 2.1 (1.5–2.7) | 1.3 (1.3–1.4) | 0.017a |
Total bilirubin (mmol/L) | 2.8 (1.5–5.6) | 1.6 (0.6–2.2) | 0.209a |
Platelet counts (/nL) | 60 (46–83) | 312 (177–462) | 0.017a |
AST (IU/L) | 28 (24–56) | 59 (43–74) | 0.097a |
ALT (IU/L) | 13 (12–39) | 52 (33–94) | 0.053a |
GGT (IU/L) | 67 (59–76) | 202 (84–485) | 0.051a |
ALP (IU/L) | 105 (83–152) | 271 (143–381) | 0.017a |
MELD score | 18 (16–36) | 14 (11–23) | 0.201b |
Data are presented as median and interquartile range (25th to 75th percentile)
LiMAx: maximum liver function capacity; INR: international normalized ratio; AST: aspartate aminotransferase; ALT: alanine aminotransferase; GGT: gamma-glutamyl transferase; ALP: alkaline phosphatase; MELD: model for end-stage liver disease
aIndependent t test
bMann–Whitney U test